Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB

Clinical trial NCT07583290 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07583290
Sponsor: Beijing Anzhen Hospital
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Cardiac Surgical Procedures Cardiopulmonary Bypass Systemic Inflammatory Response Syndrome Multiple Organ Dysfunction Syndrome Postoperative Complications

Start date: 2018-01-01
Primary completion: 2024-12-31
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.